Tools

LEADER 02180cam 2200469 i 4500

001 ocn956311075;

003 OCoLC;

005 20160808073136.0;

006 m o d f ;

007 cr |||||||||||;

008 160808s2016 dcua ob f000 0 eng c;

040 a| GPOb| enge| rdae| pnc| GPOd| MvI;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-16-594;

088 a| GAO-16-594;

110 1 a| United States.b| Government Accountability Office,e| author.=| ^A580995;

245 10 a| Medicare Part B, CMS should take additional steps to verify accuracy of data used to set payment rates for drugs :b| report to the Ranking Member, Committee on Ways and Means, House of Representatives.;

246 30 a| CMS should take additional steps to verify accuracy of data used to set payment rates for drugs;

246 3 a| Medicare Part B, Centers for Medicare and Medicaid should take additional steps to verify accuracy of data used to set payment rates for drugs;

264 1 a| [Washington, D.C.] :b| United States Government Accountability Office,c| 2016.;

300 a| 1 online resource (iii, 35 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from title screen (viewed on August 3, 2016).;

500 a| "GAO-16-594.";

500 a| "July 2016.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

610 20 a| Centers for Medicare & Medicaid Services (U.S.)x| Appropriations and expenditures.=| ^A503728;

650 0 a| Electronic data processingz| United States.=| ^A1037163;

650 0 a| Drugsx| Pricesz| United States.=| ^A30023;

650 0 a| Medicarex| Economic aspects.=| ^A6515;

856 40 u| https://purl.fdlp.gov/GPO/gpo70905;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 4535357;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4535357-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/9/2016x| EDOCUMENTz| JERESOURCE;

Medicare Part B, CMS should take additional steps to verify accuracy of data used to set payment rates for drugs : report to the Ranking Member, Committee on Ways and Means, House of Representatives.

Author/creator	United States
Other author	United States. Congress. House. Committee on Ways and Means sponsoring body.
Format	Electronic
Publication	[Washington, D.C.] : United States Government Accountability Office, 2016.
Description	1 online resource (iii, 35 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo70905
Subjects	Centers for Medicare & Medicaid Services (U.S.)--Appropriations and expenditures. Electronic data processing--United States. Drugs--Prices. --United States. Medicare--Economic aspects.

Portion of title	CMS should take additional steps to verify accuracy of data used to set payment rates for drugs
Variant title	Medicare Part B, Centers for Medicare and Medicaid should take additional steps to verify accuracy of data used to set payment rates for drugs
General note	Title from title screen (viewed on August 3, 2016).
General note	"GAO-16-594."
General note	"July 2016."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Technical rpt number	GAO-16-594
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-16-594

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Medicare Part B, CMS should take additional steps to verify accuracy of data used to set payment rates for drugs : report to the Ranking Member, Committee on Ways and Means, House of Representatives.

Click here for more information about this title

Availability